Prosecution Insights
Last updated: April 19, 2026

Turnstone Biologics Corp.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
3
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17822767 METHODS FOR EX VIVO ENRICHMENT AND EXPANSION OF TUMOR REACTIVE T CELLS AND RELATED COMPOSITIONS THEREOF GRABER, JAMES J 1631 Final Rejection Aug 26, 2022
17599446 EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS RAHMAN, MASUDUR 1633 Final Rejection Sep 28, 2021
17431692 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT CANCERS AND COMPOSITIONS THEREOF ZHU, JIANJIAN 1631 Final Rejection Aug 17, 2021

Managing Turnstone Biologics Corp.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month